EUVIMEDEUVIMED entdecken
Crossref

Hanseníase virchowiana em paciente com psoríase em uso de imunobiológico

Sheila Katchir Paulo de Oliveira, Ianna Gil de Farias Morais, Laura Rolim de Carvalho Nobrega, Maria Clara Vieira Morais, Brida Magalhães Teixeira Macedo, Esther Bastos Palitot, Joanne Elizabeth Ferraz da Costa

Revista Eletrônica Acervo Médico · 19.11.2026 · 26 · e25580

DOI: 10.25248/reamed.e25580.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Eletrônica Acervo Médico, online erschienen am 19.11.2026. Verfasst von Sheila Katchir Paulo de Oliveira und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: To report a case of multibacillary lepromatous leprosy in a patient with psoriasis and psoriatic arthritis receiving adalimumab, highlighting the clinical presentation, diagnostic investigation and therapeutic evolution. Case report: A 73-year-old man with systemic arterial hypertension, diabetes mellitus, benign prostatic hyperplasia, psoriasis and psoriatic arthritis receiving adalimumab developed asymptomatic erythematous nodular skin lesions for approximately seven months. The lesions initially appeared on the chest and subsequently spread to the face, abdomen, back and limbs. Dermatological examination showed multiple erythematous-violaceous nodules, some scaly, and infiltrated plaques. Skin biopsy demonstrated preservation of the Grenz zone, a dense lymphohistiocytic infiltrate and a high bacillary burden, reported as ++++, compatible with multibacillary lepromatous leprosy. Adalimumab was discontinued and uniform multidrug therapy was initiated. After five months, clinical improvement was observed, with reduction of the infiltrative and erythematous components and persistence of residual lesions. Final considerations: Leprosy should be considered in the differential diagnosis of infiltrative dermatoses in patients receiving anti-TNF-α therapy, particularly in endemic areas. The temporal association does not establish causality with adalimumab, but supports clinical surveillance during immunomodulation.

Zitieren

APA

Oliveira, S. K. P. D., Morais, I. G. D. F., Nobrega, L. R. D. C., Morais, M. C. V., Macedo, B. M. T., Palitot, E. B., & Costa, J. E. F. D. (2026). Hanseníase virchowiana em paciente com psoríase em uso de imunobiológico. Revista Eletrônica Acervo Médico, 26, e25580. https://doi.org/10.25248/reamed.e25580.2026

Vancouver

Oliveira SKPD, Morais IGDF, Nobrega LRDC, Morais MCV, Macedo BMT, Palitot EB, et al. Hanseníase virchowiana em paciente com psoríase em uso de imunobiológico. Revista Eletrônica Acervo Médico. 2026;26:e25580. doi:10.25248/reamed.e25580.2026

BibTeX
@article{Oliveira2026,
  author = {Oliveira, Sheila Katchir Paulo de and Morais, Ianna Gil de Farias and Nobrega, Laura Rolim de Carvalho and Morais, Maria Clara Vieira and Macedo, Brida Magalhães Teixeira and Palitot, Esther Bastos and Costa, Joanne Elizabeth Ferraz da},
  title = {Hanseníase virchowiana em paciente com psoríase em uso de imunobiológico},
  journal = {Revista Eletrônica Acervo Médico},
  year = {2026},
  volume = {26},
  pages = {e25580},
  doi = {10.25248/reamed.e25580.2026}
}
Kostenlos starten →